Giant disseminated condylomatosis in SLE

Introduction: Females with systemic lupus erythematosus (SLE) have higher prevalence of human papillomavirus (HPV) infection, which can lead to the development of warts. Herein we report the first case of giant disseminated condylomatosis (GDC) in a SLE female on mycophenolate mofetil (MMF). Case re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lupus 2012-03, Vol.21 (3), p.332-334
Hauptverfasser: CostaPinto, L, Grassi, MFR, Serravalle, K, Travessa, ACV, Olavarria, VNO, Santiago, MB
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 334
container_issue 3
container_start_page 332
container_title Lupus
container_volume 21
creator CostaPinto, L
Grassi, MFR
Serravalle, K
Travessa, ACV
Olavarria, VNO
Santiago, MB
description Introduction: Females with systemic lupus erythematosus (SLE) have higher prevalence of human papillomavirus (HPV) infection, which can lead to the development of warts. Herein we report the first case of giant disseminated condylomatosis (GDC) in a SLE female on mycophenolate mofetil (MMF). Case report: The patient, a 33-year-old, Black female, was diagnosed with SLE during her first pregnancy in 2003 based on the features of arthritis, skin rash, seizures, nephritis and presence of antinuclear antibodies. Her pregnancy resulted in preterm delivery of a stillborn fetus at 28 weeks. Since that time she has been treated with steroids and different regimens of immunosuppressive drugs such as cyclophosphamide, azathioprine and lately MMF. In the last few years she presented GDC involving the genital area in addition to skin on the lower abdomen. Topical therapy with trichloroacetic acid, imiquimod and podophyllin was only partially effective. Different types of HPV were identified in the lesions, being HPV-11 in abdomen, HPV 6, 11, 42 in vulva, HPV-6, 11 in vagina and HPV-6, 11 in endocervix. Conclusions: GDC may be a complication of SLE, secondary to the disease itself, its treatment or other factors not yet identified.
doi_str_mv 10.1177/0961203311421207
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_923200435</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0961203311421207</sage_id><sourcerecordid>920228832</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-533a01f91e1be73f1a9d2db6b1a8f7812006ff716f51dce70e8d40a12033bf3a3</originalsourceid><addsrcrecordid>eNqNkEFPwzAMhSMEYmNw54QqLnAp2EnbNEc0jYE0iQNwrtImQZnaZjTtYf9-GRsgTULiZMv-_Gw_Qi4R7hA5vweRIQXGEBMaEn5ExphwHoc6PSbjbTve9kfkzPslADAU2SkZ0RBSyvmY3M6tbPtIWe91Y1vZaxVVrlXr2jWyd976yLbR62J2Tk6MrL2-2McJeX-cvU2f4sXL_Hn6sIirhPE-ThmTgEagxlJzZlAKRVWZlShzw_NwJGTGcMxMiqrSHHSuEpBfX5SGSTYhNzvdVec-B-37orG-0nUtW-0GXwjKgkbC0n-QQGmeMxrI6wNy6YauDW8UAoUQIPIkQLCDqs5532lTrDrbyG5dIBRbt4tDt8PI1V53KButfga-7Q1AvAO8_NC_S_8U3ADWOoOm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>919990984</pqid></control><display><type>article</type><title>Giant disseminated condylomatosis in SLE</title><source>MEDLINE</source><source>SAGE Complete</source><creator>CostaPinto, L ; Grassi, MFR ; Serravalle, K ; Travessa, ACV ; Olavarria, VNO ; Santiago, MB</creator><creatorcontrib>CostaPinto, L ; Grassi, MFR ; Serravalle, K ; Travessa, ACV ; Olavarria, VNO ; Santiago, MB</creatorcontrib><description>Introduction: Females with systemic lupus erythematosus (SLE) have higher prevalence of human papillomavirus (HPV) infection, which can lead to the development of warts. Herein we report the first case of giant disseminated condylomatosis (GDC) in a SLE female on mycophenolate mofetil (MMF). Case report: The patient, a 33-year-old, Black female, was diagnosed with SLE during her first pregnancy in 2003 based on the features of arthritis, skin rash, seizures, nephritis and presence of antinuclear antibodies. Her pregnancy resulted in preterm delivery of a stillborn fetus at 28 weeks. Since that time she has been treated with steroids and different regimens of immunosuppressive drugs such as cyclophosphamide, azathioprine and lately MMF. In the last few years she presented GDC involving the genital area in addition to skin on the lower abdomen. Topical therapy with trichloroacetic acid, imiquimod and podophyllin was only partially effective. Different types of HPV were identified in the lesions, being HPV-11 in abdomen, HPV 6, 11, 42 in vulva, HPV-6, 11 in vagina and HPV-6, 11 in endocervix. Conclusions: GDC may be a complication of SLE, secondary to the disease itself, its treatment or other factors not yet identified.</description><identifier>ISSN: 0961-2033</identifier><identifier>EISSN: 1477-0962</identifier><identifier>DOI: 10.1177/0961203311421207</identifier><identifier>PMID: 21965277</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Abdomen ; Acids ; Adult ; Aminoquinolines - administration &amp; dosage ; Aminoquinolines - therapeutic use ; Arthritis ; Biopsy ; Case reports ; Cellular biology ; Condylomata Acuminata - drug therapy ; Condylomata Acuminata - etiology ; Condylomata Acuminata - virology ; Disease ; Drug Therapy, Combination ; Drugs ; Female ; Females ; Fetuses ; Human papillomavirus ; Humans ; Immunosuppressive agents ; Immunosuppressive Agents - therapeutic use ; Infections ; Lupus ; Lupus Erythematosus, Systemic - complications ; Lupus Erythematosus, Systemic - drug therapy ; Mycophenolic Acid - analogs &amp; derivatives ; Mycophenolic Acid - therapeutic use ; Papillomaviridae - classification ; Papillomaviridae - isolation &amp; purification ; Patients ; Podophyllin - administration &amp; dosage ; Podophyllin - therapeutic use ; Pregnancy ; Treatment Outcome ; Trichloroacetic Acid - administration &amp; dosage ; Trichloroacetic Acid - therapeutic use ; Vagina ; Warts</subject><ispartof>Lupus, 2012-03, Vol.21 (3), p.332-334</ispartof><rights>The Author(s), 2012. Reprints and permissions: http://www.sagepub.co.uk/journalsPermissions.nav</rights><rights>SAGE Publications © Mar 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-533a01f91e1be73f1a9d2db6b1a8f7812006ff716f51dce70e8d40a12033bf3a3</citedby><cites>FETCH-LOGICAL-c437t-533a01f91e1be73f1a9d2db6b1a8f7812006ff716f51dce70e8d40a12033bf3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0961203311421207$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0961203311421207$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21965277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CostaPinto, L</creatorcontrib><creatorcontrib>Grassi, MFR</creatorcontrib><creatorcontrib>Serravalle, K</creatorcontrib><creatorcontrib>Travessa, ACV</creatorcontrib><creatorcontrib>Olavarria, VNO</creatorcontrib><creatorcontrib>Santiago, MB</creatorcontrib><title>Giant disseminated condylomatosis in SLE</title><title>Lupus</title><addtitle>Lupus</addtitle><description>Introduction: Females with systemic lupus erythematosus (SLE) have higher prevalence of human papillomavirus (HPV) infection, which can lead to the development of warts. Herein we report the first case of giant disseminated condylomatosis (GDC) in a SLE female on mycophenolate mofetil (MMF). Case report: The patient, a 33-year-old, Black female, was diagnosed with SLE during her first pregnancy in 2003 based on the features of arthritis, skin rash, seizures, nephritis and presence of antinuclear antibodies. Her pregnancy resulted in preterm delivery of a stillborn fetus at 28 weeks. Since that time she has been treated with steroids and different regimens of immunosuppressive drugs such as cyclophosphamide, azathioprine and lately MMF. In the last few years she presented GDC involving the genital area in addition to skin on the lower abdomen. Topical therapy with trichloroacetic acid, imiquimod and podophyllin was only partially effective. Different types of HPV were identified in the lesions, being HPV-11 in abdomen, HPV 6, 11, 42 in vulva, HPV-6, 11 in vagina and HPV-6, 11 in endocervix. Conclusions: GDC may be a complication of SLE, secondary to the disease itself, its treatment or other factors not yet identified.</description><subject>Abdomen</subject><subject>Acids</subject><subject>Adult</subject><subject>Aminoquinolines - administration &amp; dosage</subject><subject>Aminoquinolines - therapeutic use</subject><subject>Arthritis</subject><subject>Biopsy</subject><subject>Case reports</subject><subject>Cellular biology</subject><subject>Condylomata Acuminata - drug therapy</subject><subject>Condylomata Acuminata - etiology</subject><subject>Condylomata Acuminata - virology</subject><subject>Disease</subject><subject>Drug Therapy, Combination</subject><subject>Drugs</subject><subject>Female</subject><subject>Females</subject><subject>Fetuses</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Immunosuppressive agents</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Infections</subject><subject>Lupus</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Lupus Erythematosus, Systemic - drug therapy</subject><subject>Mycophenolic Acid - analogs &amp; derivatives</subject><subject>Mycophenolic Acid - therapeutic use</subject><subject>Papillomaviridae - classification</subject><subject>Papillomaviridae - isolation &amp; purification</subject><subject>Patients</subject><subject>Podophyllin - administration &amp; dosage</subject><subject>Podophyllin - therapeutic use</subject><subject>Pregnancy</subject><subject>Treatment Outcome</subject><subject>Trichloroacetic Acid - administration &amp; dosage</subject><subject>Trichloroacetic Acid - therapeutic use</subject><subject>Vagina</subject><subject>Warts</subject><issn>0961-2033</issn><issn>1477-0962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkEFPwzAMhSMEYmNw54QqLnAp2EnbNEc0jYE0iQNwrtImQZnaZjTtYf9-GRsgTULiZMv-_Gw_Qi4R7hA5vweRIQXGEBMaEn5ExphwHoc6PSbjbTve9kfkzPslADAU2SkZ0RBSyvmY3M6tbPtIWe91Y1vZaxVVrlXr2jWyd976yLbR62J2Tk6MrL2-2McJeX-cvU2f4sXL_Hn6sIirhPE-ThmTgEagxlJzZlAKRVWZlShzw_NwJGTGcMxMiqrSHHSuEpBfX5SGSTYhNzvdVec-B-37orG-0nUtW-0GXwjKgkbC0n-QQGmeMxrI6wNy6YauDW8UAoUQIPIkQLCDqs5532lTrDrbyG5dIBRbt4tDt8PI1V53KButfga-7Q1AvAO8_NC_S_8U3ADWOoOm</recordid><startdate>201203</startdate><enddate>201203</enddate><creator>CostaPinto, L</creator><creator>Grassi, MFR</creator><creator>Serravalle, K</creator><creator>Travessa, ACV</creator><creator>Olavarria, VNO</creator><creator>Santiago, MB</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>201203</creationdate><title>Giant disseminated condylomatosis in SLE</title><author>CostaPinto, L ; Grassi, MFR ; Serravalle, K ; Travessa, ACV ; Olavarria, VNO ; Santiago, MB</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-533a01f91e1be73f1a9d2db6b1a8f7812006ff716f51dce70e8d40a12033bf3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Abdomen</topic><topic>Acids</topic><topic>Adult</topic><topic>Aminoquinolines - administration &amp; dosage</topic><topic>Aminoquinolines - therapeutic use</topic><topic>Arthritis</topic><topic>Biopsy</topic><topic>Case reports</topic><topic>Cellular biology</topic><topic>Condylomata Acuminata - drug therapy</topic><topic>Condylomata Acuminata - etiology</topic><topic>Condylomata Acuminata - virology</topic><topic>Disease</topic><topic>Drug Therapy, Combination</topic><topic>Drugs</topic><topic>Female</topic><topic>Females</topic><topic>Fetuses</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Immunosuppressive agents</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Infections</topic><topic>Lupus</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Lupus Erythematosus, Systemic - drug therapy</topic><topic>Mycophenolic Acid - analogs &amp; derivatives</topic><topic>Mycophenolic Acid - therapeutic use</topic><topic>Papillomaviridae - classification</topic><topic>Papillomaviridae - isolation &amp; purification</topic><topic>Patients</topic><topic>Podophyllin - administration &amp; dosage</topic><topic>Podophyllin - therapeutic use</topic><topic>Pregnancy</topic><topic>Treatment Outcome</topic><topic>Trichloroacetic Acid - administration &amp; dosage</topic><topic>Trichloroacetic Acid - therapeutic use</topic><topic>Vagina</topic><topic>Warts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CostaPinto, L</creatorcontrib><creatorcontrib>Grassi, MFR</creatorcontrib><creatorcontrib>Serravalle, K</creatorcontrib><creatorcontrib>Travessa, ACV</creatorcontrib><creatorcontrib>Olavarria, VNO</creatorcontrib><creatorcontrib>Santiago, MB</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Lupus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CostaPinto, L</au><au>Grassi, MFR</au><au>Serravalle, K</au><au>Travessa, ACV</au><au>Olavarria, VNO</au><au>Santiago, MB</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Giant disseminated condylomatosis in SLE</atitle><jtitle>Lupus</jtitle><addtitle>Lupus</addtitle><date>2012-03</date><risdate>2012</risdate><volume>21</volume><issue>3</issue><spage>332</spage><epage>334</epage><pages>332-334</pages><issn>0961-2033</issn><eissn>1477-0962</eissn><abstract>Introduction: Females with systemic lupus erythematosus (SLE) have higher prevalence of human papillomavirus (HPV) infection, which can lead to the development of warts. Herein we report the first case of giant disseminated condylomatosis (GDC) in a SLE female on mycophenolate mofetil (MMF). Case report: The patient, a 33-year-old, Black female, was diagnosed with SLE during her first pregnancy in 2003 based on the features of arthritis, skin rash, seizures, nephritis and presence of antinuclear antibodies. Her pregnancy resulted in preterm delivery of a stillborn fetus at 28 weeks. Since that time she has been treated with steroids and different regimens of immunosuppressive drugs such as cyclophosphamide, azathioprine and lately MMF. In the last few years she presented GDC involving the genital area in addition to skin on the lower abdomen. Topical therapy with trichloroacetic acid, imiquimod and podophyllin was only partially effective. Different types of HPV were identified in the lesions, being HPV-11 in abdomen, HPV 6, 11, 42 in vulva, HPV-6, 11 in vagina and HPV-6, 11 in endocervix. Conclusions: GDC may be a complication of SLE, secondary to the disease itself, its treatment or other factors not yet identified.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>21965277</pmid><doi>10.1177/0961203311421207</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0961-2033
ispartof Lupus, 2012-03, Vol.21 (3), p.332-334
issn 0961-2033
1477-0962
language eng
recordid cdi_proquest_miscellaneous_923200435
source MEDLINE; SAGE Complete
subjects Abdomen
Acids
Adult
Aminoquinolines - administration & dosage
Aminoquinolines - therapeutic use
Arthritis
Biopsy
Case reports
Cellular biology
Condylomata Acuminata - drug therapy
Condylomata Acuminata - etiology
Condylomata Acuminata - virology
Disease
Drug Therapy, Combination
Drugs
Female
Females
Fetuses
Human papillomavirus
Humans
Immunosuppressive agents
Immunosuppressive Agents - therapeutic use
Infections
Lupus
Lupus Erythematosus, Systemic - complications
Lupus Erythematosus, Systemic - drug therapy
Mycophenolic Acid - analogs & derivatives
Mycophenolic Acid - therapeutic use
Papillomaviridae - classification
Papillomaviridae - isolation & purification
Patients
Podophyllin - administration & dosage
Podophyllin - therapeutic use
Pregnancy
Treatment Outcome
Trichloroacetic Acid - administration & dosage
Trichloroacetic Acid - therapeutic use
Vagina
Warts
title Giant disseminated condylomatosis in SLE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T20%3A55%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Giant%20disseminated%20condylomatosis%20in%20SLE&rft.jtitle=Lupus&rft.au=CostaPinto,%20L&rft.date=2012-03&rft.volume=21&rft.issue=3&rft.spage=332&rft.epage=334&rft.pages=332-334&rft.issn=0961-2033&rft.eissn=1477-0962&rft_id=info:doi/10.1177/0961203311421207&rft_dat=%3Cproquest_cross%3E920228832%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=919990984&rft_id=info:pmid/21965277&rft_sage_id=10.1177_0961203311421207&rfr_iscdi=true